Literature DB >> 24500290

Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years - United States, 2014.

Iyabode Akinsanya-Beysolow.   

Abstract

Each year, the Advisory Committee on Immunization Practices (ACIP) reviews the recommended immunization schedules for persons aged 0 through 18 years to ensure that the schedules reflect current recommendations for Food and Drug Administration-licensed vaccines. In October 2013, ACIP approved the recommended immunization schedules for persons aged 0 through 18 years for 2014, which include several changes from the 2013 immunization schedules.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24500290      PMCID: PMC4584640     

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


Each year, the Advisory Committee on Immunization Practices (ACIP) reviews the recommended immunization schedules for persons aged 0 through 18 years to ensure that the schedules reflect current recommendations for Food and Drug Administration–licensed vaccines. In October 2013, ACIP approved the recommended immunization schedules for persons aged 0 through 18 years for 2014, which include several changes from the 2013 immunization schedules. Recommendations for routine use of vaccines in children, adolescents, and adults are developed by the Advisory Committee on Immunization Practices (ACIP). ACIP is chartered as a federal advisory committee to provide expert external advice and guidance to the Director of the Centers for Disease Control and Prevention (CDC) on use of vaccines and related agents for the control of vaccine-preventable diseases in the civilian population of the United States. Recommendations for routine use of vaccines in children and adolescents are harmonized to the greatest extent possible with recommendations made by the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), and the American College of Obstetrics and Gynecology (ACOG). Recommendations for routine use of vaccines in adults are harmonized with recommendations of AAFP, ACOG, and the American College of Physicians (ACP). ACIP recommendations adopted by the CDC Director become agency guidelines on the date published in the Morbidity and Mortality Weekly Report (MMWR). Additional information regarding ACIP is available at . For 2014, the figures, footnotes, and tables are not being published in MMWR; instead, a link to the CDC immunization schedule website is provided (http://www.cdc.gov/vaccines/schedules). This provides readers electronic access to the most current version of the schedules and footnotes on the CDC website. Health-care providers are advised to use both schedules and the combined footnotes together. Printable versions of the 2014 immunization schedules for persons aged 0 through 18 years also are available at the website in several formats, including portrait, landscape, and pocket-sized versions. Ordering instructions for laminated versions also are available at the website. “Parent-friendly” child and adolescent schedules are available at http://www.cdc.gov/vaccines/schedules/easy-to-read/index.html. For further guidance on use of each vaccine included in the schedules, including contraindications and precautions to use of a vaccine, health-care providers are referred to the respective ACIP vaccine recommendations at http://www.cdc.gov/vaccines/hcp/acip-recs. In addition, changes in recommendations for specific vaccines might occur between annual updates to the childhood/adolescent immunization schedules. These immunization schedules are approved by ACIP (http://www.cdc.gov/vaccines/acip/index.html), the American Academy of Pediatrics (http://www.aap.org), the American Academy of Family Physicians (http://www.aafp.org), and the American College of Obstetricians and Gynecologists (http://www.acog.org). CDC’s National Center for Immunization and Respiratory Diseases (NCIRD) maintains the most current immunization schedules on the Vaccines and Immunizations pages of CDC’s website (http://www.cdc.gov/vaccines/schedules). If errors or omissions are discovered, CDC posts revised versions on those web pages. CDC encourages organizations that previously have relied on copying the schedules on their websites instead to use content syndication to consistently display current schedules. This is a more reliable and accurate method and ensures that the most current and accurate immunization schedules are on each organization’s website. Use of content syndication requires a one-time step that assures that an organization’s website displays current schedules as soon as they are published or revised. Instructions for the syndication code are available at http://www.cdc.gov/vaccines/schedules/syndicate.html. CDC offers technical assistance for implementing this form of content syndication. Assistance from an NCIRD web team staff member is available by completing the e-mail form on the NCIRD web support page (http://www.cdc.gov/vaccines/about/contact/web_problem_form.htm). Changes to the previous schedules† include the following: Several new references were added, including the 2014 adult immunization schedule (http://www.cdc.gov/vaccines/schedules) for vaccination recommendations for persons aged ≥19 years. Recommendations for persons who have been vaccinated before the minimum age/interval between doses of vaccine in a series also were added. Figure 1, “Recommended Immunization Schedule for Persons Aged 0 through 18 Years”: – Legend for the meningococcal conjugate vaccine row updated to reflect recommendation for use of MenACWY–CRM vaccine as early as age 2 months. – Pages 4 through 6 contain combined footnotes for each vaccine related to routine vaccination, catch-up vaccination,§ and vaccination of persons with high-risk medical conditions or under special circumstances. Standardized formatting used for footnotes for each vaccine to reflect the number of vaccine doses in a particular series. Meningococcal conjugate vaccine footnotes updated to reflect recent recommendations for use of MCV4-CRM in high-risk persons aged 2 months and older. – Footnotes organized to reflect vaccine recommendations for each high-risk condition. – Influenza vaccine footnotes updated to provide guidance for dosing for children aged 6 months through 8 years for the 2013–14 and 2014–15 seasons. Pneumococcal vaccine footnotes updated to provide guidance for vaccination of persons with high-risk conditions. Hepatitis A vaccine footnotes updated to provide guidance for unvaccinated persons who are at increased risk for infection. Figure 2, Catch-Up Immunization Schedule: Haemophilus influenzae type b (Hib) conjugate vaccine, pneumococcal conjugate vaccine, and tetanus, diphtheria, and acellular pertussis (Tdap) vaccine catch-up schedules updated to provide more clarity.
  15 in total

Review 1.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study.

Authors:  Teri L Malo; Anna R Giuliano; Jessica A Kahn; Gregory D Zimet; Ji-Hyun Lee; Xiuhua Zhao; Susan T Vadaparampil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-15       Impact factor: 4.254

3.  School-Located Vaccination Clinics for Adolescents: Correlates of Acceptance Among Parents.

Authors:  Lisa M Gargano; Paul Weiss; Natasha L Underwood; Katherine Seib; Jessica M Sales; Tara M Vogt; Kimberly Rask; Christopher Morfaw; Dennis L Murray; Ralph J DiClemente; James M Hughes
Journal:  J Community Health       Date:  2015-08

4.  Automated parent-training for preschooler immunization pain relief: a randomized controlled trial.

Authors:  Lindsey L Cohen; Nikita P Rodrigues; Crystal S Lim; Donald J Bearden; Josie S Welkom; Naomi E Joffe; Patrick J McGrath; Laura A Cousins
Journal:  J Pediatr Psychol       Date:  2015-01-30

5.  Global health and U.S. health--inextricably linked.

Authors:  Chris Elias; Trevor Mundel
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

6.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

7.  Do changes in socio-demographic characteristics impact up-to-date immunization status between 3 and 24 months of age? A prospective study among an inner-city birth cohort in the United States.

Authors:  Susmita Pati; Jiayu Huang; Angie Wong; Zeinab Baba; Svetlana Ostapenko; Alexander G Fiks; Avital Cnaan
Journal:  Hum Vaccin Immunother       Date:  2017-02-27       Impact factor: 3.452

8.  Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.

Authors:  Matthew F Daley; Jason M Glanz; Sophia R Newcomer; Michael L Jackson; Holly C Groom; Marlene M Lugg; Huong Q McLean; Nicola P Klein; Eric S Weintraub; Michael M McNeil
Journal:  Vaccine       Date:  2017-03-09       Impact factor: 3.641

9.  Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.

Authors:  Matthew F Daley; Jo Ann Shoup; Sophia R Newcomer; Michael L Jackson; Holly C Groom; Steven J Jacobsen; Huong Q McLean; Nicola P Klein; Eric S Weintraub; Michael M McNeil; Jason M Glanz
Journal:  Acad Pediatr       Date:  2018-03-28       Impact factor: 3.107

10.  Temporal Trends in Undervaccination: A Population-Based Cohort Study.

Authors:  Matthew F Daley; Liza M Reifler; Jo Ann Shoup; Komal J Narwaney; Elyse O Kharbanda; Holly C Groom; Michael L Jackson; Steven J Jacobsen; Huong Q McLean; Nicola P Klein; Joshua T B Williams; Eric S Weintraub; Michael M McNeil; Jason M Glanz
Journal:  Am J Prev Med       Date:  2021-04-30       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.